MK-677 and TB-500 for muscle growth and injury recovery: what the evidence says

What did @mohamedabual3iz actually say?

This is genuinely difficult to assess. The transcript provided appears to be a heavily garbled auto-transcription of Arabic speech, producing fragments like "the small enemy" and disconnected English phrases that bear no coherent relationship to the actual video content. What we can work from is the caption, which targets men over 30 who are struggling to build muscle and fear hormones, pitching MK-677 and TB-500 as the solution, and also mentioning old injuries as an indication for these compounds.

The hashtags confirm the core claims: MK-677 as a growth hormone secretagogue alternative, TB-500 as a recovery and injury-repair peptide, and the framing of both as "natural treatment" (علاج_طبيعي). That framing matters, because neither compound is approved for human use by any major regulatory body, and calling them natural is a marketing move, not a medical classification.

Does the science back this up?

Partially, and with significant caveats that most TikTok peptide content skips entirely. MK-677 has real clinical data behind it. TB-500 has preclinical data that looks promising but has not translated into approved human therapies.

On MK-677 (ibutamoren): it is an oral ghrelin receptor agonist that stimulates growth hormone and IGF-1 secretion. A randomized controlled trial by Svensson et al. (1998, Journal of Clinical Endocrinology and Metabolism) showed sustained GH and IGF-1 elevation over two years in elderly subjects, with lean body mass improvements. Murphy et al. (1998, same journal) showed similar effects in older adults with GH deficiency. These are real findings. However, the studies also documented increased fasting glucose, insulin resistance, and in some participants, notable fluid retention and edema.

On TB-500 (Thymosin Beta-4): the peptide has shown regenerative effects in animal models, including cardiac repair (Bock-Marquette et al., 2004, Nature) and wound healing. Human clinical trials are sparse. One Phase II trial in epidermolysis bullosa did not produce the results that preclinical work suggested. Calling this an injury solution for humans is premature.

What did they get wrong (or right)?

Credit where it is due: MK-677 does stimulate GH and IGF-1 in aging adults, and there is peer-reviewed evidence supporting that mechanism. If the argument is that men over 30 experience declining GH and that MK-677 addresses that, the biology is not wrong. That part holds up.

What the video gets wrong, based on the caption framing, is the "natural treatment" label and the implication that these compounds are a safe, side-effect-free alternative to hormone therapy. MK-677 is not natural in any meaningful sense. It is a synthetic, non-peptide compound. It is also not approved by the FDA, EMA, or any comparable body for these uses.

Describing TB-500 as a solution for old injuries in humans goes well beyond what the current evidence supports. Animal data on tissue repair is interesting. It does not mean the compound reliably repairs a torn labrum or chronic tendinopathy in a 35-year-old. That leap is misleading and potentially costly to someone who delays legitimate medical care based on it.

What should you actually know?

MK-677 has a real pharmacological profile and its effects on GH and IGF-1 are documented, not fabricated. But it comes with risks that are consistently underplayed in bodybuilding content: insulin resistance, increased appetite leading to fat gain if diet is not controlled, potential cortisol elevation, and water retention. Nass et al. (2008, Annals of Internal Medicine) found no significant improvement in functional outcomes in older adults despite GH increases, which raises questions about whether the hormonal changes actually translate to real-world performance benefits.

TB-500's human data is thin. It is not approved anywhere for injury treatment. People using it are doing so entirely outside any regulated framework, which means quality, dosing accuracy, and safety monitoring are all unknowns.

Anyone over 30 experiencing difficulty building muscle should first rule out modifiable factors: sleep, protein intake, training programming, and testosterone levels through a standard blood panel. Peptides are not a first-line answer, and a TikTok caption is not a clinical consultation.